Expansion potential Vivacy is present in over 70 countries with a growing global footprint and recent strategic partnerships, indicating ample cross-border sales opportunities in distribution, training, and co-branded marketing with clinics and retailers.

Strategic partnerships Recent collaboration with Obagi Cosmeceuticals and a planned commercial partnership suggest a path to integrated skincare and injectable offerings, enabling bundled solutions and channel expansion with dermatology and aesthetic practices.

New product launches Introduction of biostimulatory injectables in 2026 and ongoing IPN-Like technology leadership create opportunities to upsell advanced formulations, trainings, and patient programs to clinics seeking innovative regenerative aesthetics.

Key appointments Appointment of a UK and Ireland sales director and expanded leadership signals focus on strengthening regional sales execution, enabling targeted outreach to clinics, distributers, and aesthetics networks in high-potential markets.

Manufacturing advantage All products are French-manufactured at a high-tech facility, supporting perceived quality and compliance. This can be leveraged in value-based selling to premium clinics prioritizing GMP-certified, traceable supply chains and reliability.